Can Fite Biopharma Ltd CANF:NYSE American

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 4:00 PM EDT
2.09quote price arrow up+0.02 (+0.97%)
Volume
27,154
52 week range
1.71 - 3.33
Loading...
  • Open2.12
  • Day High2.12
  • Day Low2.00
  • Prev Close2.07
  • 52 Week High3.33
  • 52 Week High Date06/15/23
  • 52 Week Low1.71
  • 52 Week Low Date05/01/23

Key Stats

  • Market Cap9.88M
  • Shares Out4.99M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta0.99
  • YTD % Change-5

KEY STATS

  • Open2.12
  • Day High2.12
  • Day Low2.00
  • Prev Close2.07
  • 52 Week High3.33
  • 52 Week High Date06/15/23
  • 52 Week Low1.71
  • 52 Week Low Date05/01/23
  • Market Cap9.88M
  • Shares Out4.99M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta0.99
  • YTD % Change-5

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/30/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Can Fite Biopharma Ltd

 

Profile

MORE
Can Fite Biofarma Ltd is an Israel-based clinical-stage biopharmaceutical company engaged in developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The Company co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. It's technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is...
Ilan Cohen
Chairman of the Board
Pnina Fishman Ph.D.
Chief Executive Officer, Director
Motti Farbstein
Chief Financial Officer, Chief Operating Officer
Address
26 Ben Gurion Street
Ramat Gan
5257346
Israel

Top Peers

SYMBOLLASTCHG%CHG
LGVN
Longeveron Inc
1.74+0.03+1.75%
BCDA
BioCardia Inc
0.3762-0.0109-2.8158%
NTBL
Notable Labs Ltd
0.914-0.006-0.6468%
VCNX
Vaccinex Inc
6.18+0.24+4.04%
ONVO
Organovo Holdings Inc
0.9311-0.1389-12.9813%